S
Zodix
Study
Academic Library
Search
Shelves
Open access
Sign in
Search or jump to…
⌘K
Anne Eckert · Study
Home
/
Author
Anne Eckert
15 works
· latest 2023
· 1 institutions
cluster: provisional
ORCID 0000-0002-9341-3669
Follow
Suggest an ORCID correction
h-index
15
i10
15
Citations
1,790
Works here
15
13
19
20
21
22
23
Most cited in this library
Distinct acute effects of LSD, MDMA, and d-amphetamine in healthy subjects
2019 · 246 citations
Acute dose-dependent effects of lysergic acid diethylamide in a double-blind placebo-controlled study in healthy subjects
2020 · 242 citations
Direct comparison of the acute effects of lysergic acid diethylamide and psilocybin in a double-blind placebo-controlled study in healthy subjects
2022 · 225 citations
Acute Effects of Psilocybin After Escitalopram or Placebo Pretreatment in a Randomized, Double‐Blind, Placebo‐Controlled, Crossover Study in Healthy Subjects
2021 · 184 citations
Low Doses of LSD Acutely Increase BDNF Blood Plasma Levels in Healthy Volunteers
2020 · 130 citations
Works
15 shown
Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants
Neuropsychopharmacology
·
2023
·
14 authors
·
Open access
129
citations
Acute effects of intravenous DMT in a randomized placebo-controlled study in healthy participants
Translational Psychiatry
·
2023
·
15 authors
·
Open access
89
citations
Oxytocin in response to MDMA provocation test in patients with arginine vasopressin deficiency (central diabetes insipidus): a single-centre, case-control study with nested, randomised, double-blind, placebo-controlled crossover trial
The Lancet Diabetes & Endocrinology
·
2023
·
11 authors
64
citations
Ketanserin Reverses the Acute Response to LSD in a Randomized, Double-Blind, Placebo-Controlled, Crossover Study in Healthy Participants
The International Journal of Neuropsychopharmacology
·
2022
·
8 authors
·
Open access
104
citations
Direct comparison of the acute effects of lysergic acid diethylamide and psilocybin in a double-blind placebo-controlled study in healthy subjects
Neuropsychopharmacology
·
2022
·
12 authors
·
Open access
225
citations
Acute Effects of Psilocybin After Escitalopram or Placebo Pretreatment in a Randomized, Double‐Blind, Placebo‐Controlled, Crossover Study in Healthy Subjects
Clinical Pharmacology & Therapeutics
·
2021
·
11 authors
·
Open access
184
citations
Role of the 5-HT2A Receptor in Acute Effects of LSD on Empathy and Circulating Oxytocin
Frontiers in Pharmacology
·
2021
·
5 authors
·
Open access
67
citations
Acute dose-dependent effects of lysergic acid diethylamide in a double-blind placebo-controlled study in healthy subjects
Neuropsychopharmacology
·
2020
·
11 authors
·
Open access
242
citations
Low Doses of LSD Acutely Increase BDNF Blood Plasma Levels in Healthy Volunteers
ACS Pharmacology & Translational Science
·
2020
·
11 authors
·
Open access
130
citations
Hypothalamic-pituitary-adrenal axis activation in a high-risk sample of children, adolescents and young adults in residential youth care – Associations with adverse childhood experiences and mental health problems
Psychiatry Research
·
2020
·
7 authors
32
citations
Effect of trauma-informed care on hair cortisol concentration in youth welfare staff and client physical aggression towards staff: results of a longitudinal study
BMC Public Health
·
2020
·
6 authors
·
Open access
40
citations
Distinct acute effects of LSD, MDMA, and d-amphetamine in healthy subjects
Neuropsychopharmacology
·
2019
·
9 authors
·
Open access
246
citations
Brain-derived neurotrophic factor is a biomarker for subjective insomnia but not objectively assessable poor sleep continuity
Journal of Psychiatric Research
·
2019
·
5 authors
39
citations
The Interplay of Stress and Sleep Impacts BDNF Level
PLoS ONE
·
2013
·
6 authors
·
Open access
99
citations
BDNF: an indicator of insomnia?
Molecular Psychiatry
·
2013
·
8 authors
·
Open access
100
citations